Meet Shan Boldt, who had been battling a toe wound for months and faced the harsh reality of a possible amputation. With the introduction of Mirragen, a borate-based bioactive glass wound matrix, Shan’s toe reached closure after just six weeks and seven applications. As a result, Shan is able to move around more freely and do the things he loves in life.